The aim of this study is to integrate insights from metabolomics and TCMBC to identify biomarkers and physiological pathways associated with CRF.
Patients aged 18 years or older
Diagnosed with stage I to III CRC and scheduled for surgical treatment
Cognitively intact and able to communicate in either Mandarin or Taiwanese
Willing to participate in the study and provide written informed consent.
Patients diagnosed with stage IV colorectal cancer
Patients with recurrent colorectal cancer or other concurrent cancers.
Newly diagnosed with stage I to III CRC and scheduled for surgical treatment
Cohort
Prospective
Not listed
Self-report Questionnaire
The study utilizes two instruments. First, the Fatigue Symptom Inventory (FSI) is used to assess fatigue; total scores range from 0 to 127, with higher scores indicating greater fatigue severity. Second, the Body Constitution Questionnaire (BCQ) comprises 16 items, with total scores ranging from 16 to 80.
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options:
